Evidence map›Paper›PMID 23519116›Full record

ArticleCell death & disease2013

A myosin-Va tail fragment sequesters dynein light chains leading to apoptosis in melanoma cells.

T C Izidoro-Toledo, A C Borges, D D Araújo, D P S Leitão Mazzi, F O Nascimento Júnior, J F Sousa, C P Alves, A P B Paiva, D M Trindade, E V Patussi and 3 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

T C Izidoro-ToledoDepartment of Cellular and Molecular Biology and Pathogenic Bioagents, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil.
A C Borges
D D Araújo
D P S Leitão Mazzi
F O Nascimento Júnior
J F Sousa
C P Alves
A P B Paiva
D M Trindade
E V Patussi
P M Peixoto
K W Kinnally
E M Espreafico
Universidade de São Paulo · BRNew York University · USBrazilian Biosciences National Laboratory · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies proposed that myosin-Va regulates apoptosis by sequestering pro-apoptotic Bmf to the actin cytoskeleton through dynein light chain-2 (DLC2). Adhesion loss or other cytoskeletal perturbations would unleash Bmf, allowing it to bind and inhibit pro-survival Bcl2 proteins. Here, we demonstrated that overexpression of a myosin-Va medial tail fragment (MVaf) harboring the binding site for DLC2 dramatically decreased melanoma cell viability. Morphological and molecular changes, including surface blebbing, mitochondrial outer membrane permeabilization, cytochrome-c and Smac release, as well as caspase-9/-3 activation and DNA fragmentation indicated that melanoma cells died of apoptosis. Immobilized MVaf interacted directly with DLCs, but complexed MVaf/DLCs did not interact with Bmf. Overexpression of DLC2 attenuated MVaf-induced apoptosis. Thus, we suggest that, MVaf induces apoptosis by sequestering DLC2 and DLC1, thereby unleashing the pair of sensitizer and activator BH3-only proteins Bmf and Bim. Murine embryonic fibroblasts (MEFs) lacking Bim and Bmf or Bax and Bak were less sensitive to apoptosis caused by MVaf expression than wild-type MEFs, strengthening the putative role of the intrinsic apoptotic pathway in this response. Finally, MVaf expression attenuated B16-F10 solid tumor growth in mice, suggesting that this peptide may be useful as an apoptosis-inducing tool for basic and translational studies.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsApoptosisApoptosis Regulatory Proteinsbcl-2 Homologous Antagonist-Killer ProteinBcl-2-Like Protein 11Cell Line, TumorCytoplasmic DyneinsDNA FragmentationFibroblastsGene Expression Regulation, NeoplasticHumansMelanomaMembrane ProteinsMiceMice, KnockoutAdaptor Proteins, Signal TransducingApoptosis Regulatory ProteinsBak1 protein, mousebcl-2 Homologous Antagonist-Killer ProteinBCL2L11 protein, humanBcl2l11 protein, mouseBcl-2-Like Protein 11BMF protein, humanCytoplasmic DyneinsDYNLL1 protein, humanDYNLL2 protein, humanMembrane ProteinsMYO5A protein, humanMyosin Heavy ChainsMyosin Type VPeptide FragmentsProto-Oncogene Proteins

Identifiers

PMID23519116
PMCPMC3613824
OpenAlexW2035718470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.